MGMT gene promoter methylation in humoral tissue as biomarker for lung cancer diagnosis: An update meta‐analysis
Abstract Objective To investigate O‐6‐methylguanine‐DNA methyltransferase (MGMT) gene promoter methylation in humoral tissue as biomarker for lung cancer diagnosis by pooling relevant open published data. Methods Clinical studies relevant to MGMT gene promoter methylation and lung cancer were system...
Guardado en:
Autores principales: | Bizheng Chen, Xiaozhen Ying, Liming Bao |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Wiley
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9eae6dbdf0534983bab8a15a58db5472 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Lack of Benefit of Extending Temozolomide Treatment in Patients with High Vascular Glioblastoma with Methylated <i>MGMT</i>
por: María del Mar Álvarez-Torres, et al.
Publicado: (2021) -
Diagnostic, Predictive, and Prognostic Biomarkers in Non-Small Cell Lung Cancer (NSCLC) Management
por: Maja Šutić, et al.
Publicado: (2021) -
Novel Methylation Biomarkers for Colorectal Cancer Prognosis
por: Alvaro Gutierrez, et al.
Publicado: (2021) -
High frequency of p 16 promoter methylation in non-small cell lung carcinomas from Chile
por: GUZMAN,LEDA M, et al.
Publicado: (2007) -
MIND MGMT: Paranoid Nightmares of a Fugitive Reality.
por: Pepe Rojo
Publicado: (2017)